cancer australia - grants reporting · web view2017/07/03 · priority driven collaborative cancer...

Grants ReportingThe following table details all grants that Cancer Australia has funded since 1 January 2009.

Agency Program Title

Program Component

(if applicable)

Recipient Purpose Value Date of Effect

Grant Term

(months)

Grant Funding Location Postcode

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

Cancer Council Victoria

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A web-based intervention to reduce distress and improve quality of life among younger women with breast cancer: A RCT. App562002. CA-A0809/05

$109,937.18 15/12/2008 53 Carlton 3053

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

Queensland Institute of Medical Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Towards new screening tests for oesophageal adenocarcinoma Appl ID: 552449

$512,325 01/01/2009 59 Herston QLD 4006

Cancer Australia


University of Newcastle

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Targeting p53 isoforms, Δ40p53 and p53β, to promote chemo-sensitivity in human melanoma. App569284. CA-A0809/49

$20,625 04/01/2009 12 Callaghan 2308

Cancer Australia


Queensland Health

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Phase II Efficacy Study of Chemo-Radiotherapy in PET Staged II-III Merkel Cell Carcinoma of the Skin. App551200. CA-A0809/06

$101,750 13/01/2009 72 Woolloongabba 4102

Cancer Australia


University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Psychological morbidity, unmet needs, quality of life and patterns of care in migrant cancer patients: The first year. App571009. CA-A0809/37

$20,229.83 14/01/2009 12 Sydney 2006

1 of 54


Program Component

(if applicable)


Grant Term

(months)


Cancer Australia


The University of Wollongong

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: In vivo assessment of small molecule uPA-directed prodrugs for the treatment of malignant disease. App573432. CA-A0809/09

$20,556.25 14/01/2009 25 Wollongong 2522

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The role of intraprostatic glucocorticoid action in prostate physiology and pathology. App571311. CA-A0809/10

$20,229.83 14/01/2009 12 Sydney 2006

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Identification of candidate tumour suppressor genes inactivated by promoter methylation in melanoma cell lines. App552466. CA-A0809/25

$20,556.25 20/01/2009 12 Herston 4006

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Response to chemotherapy in ovarian cancer. App552481. CA-A0809/22

$625,625 20/01/2009 39 Herston 4006

Cancer Australia

Support for Cancer Clinical Trials Program and Boost Cancer Research Program

Primary Care Collaborative Clinical trials Group (PC4TG) through University of Western Australia

Support for Cancer Clinical Trials Program - CA-A0910/16

$311,230.70 27/01/2009 17 University of WA, WA 6009

Cancer Australia


Macquarie University

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Evaluation of an online decision aid for women with breast cancer considering reconstructive surgery. App543400. CA-A0809/29

$103,803.34 30/01/2009 60 North Ryde 2109

Cancer Australia


University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The Renin Angiotensin System – a Novel Target in the Treatment of Colorectal

$20,363.20 30/01/2009 18 Parkville 3010

2 of 54


Program Component

(if applicable)


Grant Term

(months)


Liver Metastases. App566536. CA-A0809/47

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Overcoming chemo-resistance in leukaemia: application of Vorinostat and ABT-737 to a new in vivo model of CLL. App566746. CA-A0809/46

$20,350 30/01/2009 12 Parkville 3010

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Characterisation of the kConFab BRCAX cohort for selected breast cancer susceptibility loci and effect on cancer risk. App566791. CA-A0809/44

$527,107.90 30/01/2009 71 Parkville 3010

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A randomised trial of stereotactic vs conventional radiotherapy for inoperable early stage non-small cell lung cancer. App566813. CA-A0809/45

$286,000 30/01/2009 59 Parkville 3010

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Methylation in ductal carcinoma in situ. App566882. CA-A0809/43

$294,398.69 30/01/2009 48 Parkville 3010

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Characterisation of a tumour-associated PIK3CA mutation using a novel mouse model. App566974. CA-A0809/42

$20,625 30/01/2009 12 Parkville 3010

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Reversing the debilitating effects of radiotherapy-induced damage in juvenile brain. App566976. CA-A0809/41

$20,625 30/01/2009 12 Parkville 3010

Cancer Australia

Support for Cancer Clinical Trials Program

Australian and New Zealand Children’s


$770,880.00 30/01/2009 18 Parkville 3052

3 of 54


Program Component

(if applicable)


Grant Term

(months)


Haematology/Oncology Group (ANZCHOG)

Cancer Australia


Australasian Sarcoma Study Group (ASSG) through University of Melbourne


$760,839.20 30/01/2009 18 University of Melbourne, VIC 3010

Cancer Australia


Garvan Institute of Medical Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: DNA methylation alterations as detection markers for early ovarian cancer. App535957. CA-A0809/28

$639,375 02/02/2009 36 Darlinghurst 2010

Cancer Australia


University of NSW

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Role of Heat Shock Proteins in the Stromal Reaction of Pancreatic Cancer. App568851. CA-A0809/27

$20,350 02/02/2009 12 Sydney 2052

Cancer Australia


Melbourne Health

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Resveratrol in the chemoprevention of colorectal neoplasia. App544307. CA-A0809/39

$633,325 03/02/2009 60 Parkville 3050

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A nurse led psychosocial intervention with peer support to reduce psychosocial needs in women with gynaecological cancer. App566942. CA-A0809/40

$127,930 03/02/2009 24 Parkville 3010

Cancer Australia


Cooperative Trials Group for Neuro-Oncology (COGNO) through University of Sydney


$364,455.30 03/02/2009 17 University of Sydney, NSW 2006

Cancer Australia


Prince Charles Hospital

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Individualising treatment for mesothelioma. App550600. CA-A0809/48

$384,450 04/02/2009 50 Chermside 4032

Cancer Priority Driven University of Priority Driven Collaborative $285,360.90 04/02/2009 52 Callaghan 23084 of 54


Program Component

(if applicable)


Grant Term

(months)


AustraliaCollaborative Cancer Research Scheme

Newcastle

Cancer Research Scheme (PDCCRS) 2008: Blood cancer survivors and support persons: A national survey of rural/urban unmet needs and psychological disturbance. App569290. CA-A0809/50

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Incidence and risk factors for lymphoedema secondary to breast cancer: a prospective cohort study. App570801. CA-A0809/30

$581,916.25 04/02/2009 48 Sydney 2006

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Quality of life outcomes and cost effectiveness of pelvic exenteration for people with advanced rectal cancer. App570860. CA-A0809/31

$211,777.50 04/02/2009 71 Sydney 2006

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Phase III study in patients with Locally Advanced Pancreatic cancer: Gemcitabine +/- chemoradiotherapy & +/- erlotinib. App570948. CA-A0809/34

$284,900 04/02/2009 90 Sydney 2006

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Genome-wide analysis of pre-mRNA splicing regulation by RBM4. App570874. CA-A0809/32

$20,597.50 05/02/2009 12 Sydney 2006

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Understanding the psychosocial sequelae of surviving testicular cancer. App570961. CA-A0809/35

$104,940 05/02/2009 24 Sydney 2006

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Short Course Oncology Therapy - A Study of Adjuvant

$329,752.50 05/02/2009 59 Sydney 2006

5 of 54


Program Component

(if applicable)


Grant Term

(months)


Chemotherapy in Colorectal Cancer by the CACTUS and OCTO Groups. App571314. CA-A0809/38

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The role of melanoma stem cells in melanomagenesis. App570778. CA-A0809/21

$20,625 09/02/2009 12 Sydney 2006

Cancer Australia


University of Southern Queensland

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A Randomized Trial of a Shorter Radiation Fractionation Schedule for the Treatment of Localized Prostate Cancer (PROFIT – Prostate Fractionated Irradiation Trial). App570403. CA-A0809/20

$487,850 12/02/2009 36 Toowoomba 4350

Cancer Australia


Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) through University of Sydney


$839,905.00 18/02/2009 18 University of Sydney, NSW 2006

Cancer Australia


Walter and Eliza Hall Institute

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Role of the GATA-3 transcription factor as a tumour suppressor and potential therapeutic target in breast cancer. App575572. CA-A0809/53

$326,803.95 20/02/2009 36 Parkville 3050

Cancer Australia


University of Adelaide

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Faecal microflora and circulating proinflammatory cytokines: key elements to chemotherapy-induced diarrhoea. App553601. CA-A0809/54

$20,625 25/02/2009 12 Adelaide 5005

Cancer Australia

Improved Cancer Control


Cancer Institute NSW

The continuation of Cancer Service Networks National Demonstration Program (CanNET) in New South Wales

$932,091.60 16/03/2009 56 Alexandria, NSW 1435

6 of 54


Program Component

(if applicable)


Grant Term

(months)


Cancer Australia


University of NSW

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Development of an optimised multidisciplinary intervention for post-cancer fatigue. App568828. CA-A0809/64

$474,650 15/06/2009 61 Sydney 2052

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: A combinatorial approach targeting androgen signalling for treatment of prostate cancer. App627229. CA-A0910/87

$321,028.95 01/01/2010 36 Adelaide 5005

Cancer Australia


University of South Australia

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Development of microfluidic chips to isolate and analyse peripheral blood cell populations in pancreatic cancer patients. App631921. CA-A0910/56

$24,750 06/01/2010 12 Adelaide 5001

Cancer Australia


Ludwig Institute of Cancer Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Mechanisms of abiraterone resistance in prostate cancer. App603107. CA-A0910/57

$216,150 18/01/2010 36 Heidelberg 3084

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Identifying and targeting Docetaxel resistance in hormone refractory prostate cancer. App596858. CA-A0910/54

$213,950 20/01/2010 36 Darlinghurst 2010

Cancer Australia


Monash University

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: The role of the EphA3 receptor in the stromal microenvironment of tumours. App606719. CA-A0910/58

$24,750 20/01/2010 12 Clayton 3168

Cancer Australia


Monash University Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Novel monoclonal antibodies for the diagnosis and treatment of epithelial cancers and

$94,806.80 21/01/2010 12 Clayton 3168

7 of 54


Program Component

(if applicable)


Grant Term

(months)


cancer stem cells. App606552. CA-A0910/55

Cancer Australia


University of Queensland

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: LACE – Laparoscopic Approach to Carcinoma of the Endometrium. An International Multicentre Randomised Phase 3 Clinical Trial. App631523. CA-A0910/46

$643,775 27/01/2010 36 Brisbane 4072

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Lymphocyte receptors that regulate tumor development and therapy. App628304. CA-A0910/49

$24,571.80 29/01/2010 12 Parkville 3010

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Preventing Breast Cancer in BRCA1 and BRCA2 Mutation Carriers: kConFab Follow-Up Project. App628333. CA-A0910/51

$327,731.25 29/01/2010 36 Parkville 3010

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Identification of BRCAx Genes through targeted next generation sequencing. App628610. CA-A0910/52

$231,000 29/01/2010 36 Parkville 3010

Cancer Australia


Ludwig Institute of Cancer Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: IL-11: A preclinical target for inflammation-associated gastrointestinal cancer. App603121. CA-A0910/45

$24,750 01/02/2010 12 Heidelberg 3084

Cancer Australia


University of New South Wales

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Too much, too soon? The impact of treatment-focused genetic testing in patients newly diagnosed with breast cancer. App630405. CA-A0910/62

$217,998 09/02/2010 42 Sydney 2052

Cancer Australia

Priority Driven Collaborative


Priority Driven Collaborative Cancer Research Scheme $24,181.58 12/02/2010 12 Parkville 3010

8 of 54


Program Component

(if applicable)


Grant Term

(months)


Cancer Research Scheme

(PDCCRS) 2009: Characterization of the immunoregulatory capacity of antibody-based immunotherapeutics in established cancer. App628338. CA-A0910/48

Cancer Australia


Curtin University of Technology

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Examination of surgical margins with a positron emission tomography (PET) probe in DCIS and invasive breast cancer. App594409. CA-A0910/64

$41,937.50 17/02/2010 24 Perth 6845

Cancer Australia


Trans Tasman Radiation Oncology Group Limited

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Phase II Trial of Integrated Preoperative RT/Chemo with Oxaliplatin, 5-FU and FA in Locally Advanced Rectal Cancer. App626200. CA-A0910/65

$118,250 23/02/2010 40 Waratah 2298

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Altered nucleotide excision repair in melanoma in response to cisplatin and UV-light irradiation. App631019. CA-A0910/63

$24,750 24/02/2010 15 Callaghan 2308

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: The role of microRNAs in the progression of ductal carcinoma in situ to invasive breast cancer. App632547. CA-A0910/69

$24,750 24/02/2010 12 Sydney 2006

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Timing of surgery and adjuvant chemotherapy for hepatic metastases from colorectal cancer. App632737. CA-A0910/73

$660,000 24/02/2010 53 Sydney 2006

Cancer Australia

Priority Driven Collaborative


Priority Driven Collaborative Cancer Research Scheme $209,481.80 24/02/2010 39 Sydney 2006

9 of 54


Program Component

(if applicable)


Grant Term

(months)



(PDCCRS) 2009: Phase 2 study of aromatase inhibitors in women with potentially hormone sensitive recurrent/metastatic gynaecological neoplasms: PARAGON. App632740. CA-A0910/75

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: hOGG1 in human skin carcinogenesis. App632760. CA-A0910/74

$23,443.75 24/02/2010 12 Sydney 2006

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Randomised trial of consumer-led familial cancer risk tool & GP triage on risk-appropriate colorectal cancer screening. App632887. CA-A0910/70

$537,901.37 24/02/2010 46 Sydney 2006

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Telomere trimming: a novel mechanism for preventing unlimited cellular proliferation. App633214. CA-A0910/72

$23,443.75 24/02/2010 12 Sydney 2006

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Post-operative enteral nutrition in patients with advanced epithelial ovarian cancer. App631524. CA-A0910/77

$261,910 25/02/2010 36 Brisbane 4072

Cancer Australia


Monash University

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Pilot of a population-based prostate cancer clinical registry. App606927. CA-A0910/80

$217,387.50 26/02/2010 36 Clayton 3168

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Control of malignant glioma by naturally occurring oncolytic enteroviruses. App631059. CA-A0910/68

$23,426.70 02/03/2010 12 Callaghan 2308

10 of 54


Program Component

(if applicable)


Grant Term

(months)


Cancer Australia


CSIRO

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: The effects of microencapsulated butyrylated high amylose maize starch and fish oil on colorectal cancer risk in rats. App593504. CA-A0910/88

$23,153.63 19/03/2010 12 Adelaide 5000

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: A randomised controlled trial evaluating a nurse-led survivorship care package (SurvivorCare) for bowel cancer survivors. App628581. CA-A0910/86

$206,250 29/03/2010 48 Parkville 3010

Cancer Australia

Support for Cancer Clinical Trials Program and Boost Cancer Research Program

Primary Care Collaborative Clinical trials Group (PC4TG) through University of Western Australia


$1,506,347.70 22/06/2010 36 University of WA, WA 6009

Cancer Australia


Trans-Tasman Radiation Oncology Group Limited (TROG)

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: A randomised comparison of anastrozole commenced before and continued during adjuvant radiotherapy for breast cancer versus anastrozole and subsequent anti-oestrogen therapy delayed until after radiotherapy ApplID: 626201

$660,000 25/06/2010 48 Newcastle, NSW 2310

Cancer Australia


Australasian Gastro-Intestinal Trials Group (AGITG) through University of Sydney


$1,541,030.40 25/06/2010 36 University of Sydney,

NSW 2006

Cancer Australia


Australasian Leukaemia and Lymphoma Group (ALLG)


$1,549,296.10 25/06/2010 36 East Melbourne, 3002

Cancer Australia


Australasian Lung Cancer Trials Group (ALTG) through University of


$1,523,481.30

25/06/2010 36 University of Sydney, NSW

2006

11 of 54


Program Component

(if applicable)


Grant Term

(months)


Sydney

Cancer Australia


Australia and New Zealand Breast Cancer Trials Group (ANZBCTG)


$1,541,639.00 25/06/2010 36 Waratah, NSW 2298

Cancer Australia


Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG)


$1,547,700.00 25/06/2010 36 Royal Melbourne

Hospital, VIC 3050

Cancer Australia


Australia New Zealand Gynaecological Oncology Group (ANZGOG) through University of Sydney



NSW 2006

Cancer Australia


Australia and New Zealand Melanoma Trials Group (ANZMTG) through University of Sydney



NSW 2006

Cancer Australia


Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) through University of Sydney



NSW 2006

Cancer Australia


Australasian Sarcoma Study Group (ASSG) through University of Melbourne


$1,536,150.00 25/06/2010 36 University of

Melbourne, VIC 3010

Cancer Australia


Cooperative Trials Group for Neuro-Oncology (COGNO) through University of Sydney



NSW 2006

Cancer Australia


Psycho-oncology Co-operative Research Group (PoCoG) through University of


$1,627,835.00

25/06/2010 36 University of Sydney, NSW

2006

12 of 54


Program Component

(if applicable)


Grant Term

(months)


Sydney

Cancer Australia


TransTasman Radiation Oncology Group (TROG)

Support for Cancer Clinical Trials Program -CA-A0910/125

$1,549,297.20 25/06/2010 36 Waratah, NSW 2287

Cancer Australia



Anti - Cancer Foundation of South Australia

Continuing Implementation of the National Cancer Data Strategy

$34,402.50 01/01/2011 3 Eastwood SA 5063

Cancer Australia



2010 PdCCRS: microRNA miR-211 as a novel tumour suppressor for melanoma. App1011300

$49,500.00 21/01/2011 20 Herston QLD 4006

Cancer Australia



2010 PdCCRS: Development of a model to classify mismatch repair gene sequence variants of uncertain clinical significance. App1010859

$660,000.00 21/01/2011 48 Herston QLD 4006

Cancer Australia


Griffith University

2010 PdCCRS: ProsCan for Life: A Multimodal Supportive Care Intervention for Men with Prostate Cancer. App1008320

$329,006.70 24/01/2011 36 Nathan QLD 4111

Cancer Australia


Cancer Council QLD

2010 PdCCRS - A multi-level investigation of inequalities in clinical and psychosocial outcomes for women after breast cancer. App1006339

$647,619.50 02/02/2011 36 Fortitude Valley, QLD 4006

Cancer Australia


The University of Western Australia

2010 PdCCRS: Endocrine therapies for early breast cancer: health outcomes and policy implications in Australian clinical practice. Targets the National Health Priority Area of Cancer Control, specifically focussing on breast cancer treatment in Australian women. App1011488

$171,048.90 04/02/2011 49 Crawley WA 6009

Cancer Australia



2010 PdCCRS: Identifying markers of risk and outcome in ovarian and breast cancer via efficient of DNA methylation in peripheral blood. App1011143

$191,213.00 08/02/2011 46 Herston QLD 4006

Cancer Australia



2010 PdCCRS: Genetic and environmental factors in invasive cervical cancer: a twin study. App1008811

$429,458.70 09/02/2011 36 Parkville VIC 3010

13 of 54


Program Component

(if applicable)


Grant Term

(months)


Cancer Australia



2010 PdCCRS: Fulfilling the vision of youth-friendly cancer care: How well are we meeting the psychosocial needs of AYA patients? App1010977

$164,776.70 09/02/2011 42 Parkville VIC 3010

Cancer Australia


Originally University of Melbourne now Ludwig Institute of Cancer Research

2010 PdCCRS: Identifying therapeutic targets by profiling DNA repair in lung cancer CA-A1011/18. App1009892

$552,776.40 09/02/2011 46 Heidelberg VIC 3084

Cancer Australia



2010 PdCCRS: Personalised breast cancer risk prediction in BRCA mutation carriers. App1007765

$152,780.10 09/02/2011 63 Parkville VIC 3010

Cancer Australia



2010 PdCCRS: Identification of Men with a genetic predisposition to Prostate Cancer: targeted screening in BRCA1/2 mutation carriers and controls - The Impact study. App1006349

$465,329.70 09/02/2011 40 Parkville VIC 3010

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2010: A phase III randomised trial of postmastectomy chest wall irradiation in intermediate risk operable breast cancer. App1004707. CA-A1011/15

$561,000 09/02/2011 36 Parkville 3010

Cancer Australia


The Australian National University

2010 PdCCRS: Targeting of two Aspects of Metabolism (TOTAM) for cancer therapy. App1008861

$546,165.40 14/02/2011 36 Canberra ACT 200

Cancer Australia



2010 PdCCRS: Identification of anti-apoptotic signalling pathways in malignant gliomas. App1010484

$49,500.00 15/02/2011 12 Sydney NSW 2052

Cancer Australia



2010 PdCCRS: Role of dietary compounds on PGC-1 alpha methylation in colorectal cancer. App1010361

- 15/02/2011 36 Sydney NSW 2052

Cancer Australia

Priority-driven Collaborative Cancer Research


2010 PdCCRS: Targeting drug resistant genes in brain cancer: delivery of siRNA to improve cancer therapy.

$49,500.00 15/02/2011 19 Sydney NSW 2052

14 of 54


Program Component

(if applicable)


Grant Term

(months)


Scheme App1003650

Cancer Australia



Autofluorescence imaging for early detection and surgical margin delineation of oral cancers and pre-cancers. App1009996

$558,131.20 21/02/2011 44 St Lucia, QLD 4072

Cancer Australia



The role of CD123 in MDSA and AML. App1010336 $316,276.40 24/02/2011 36 North Terrace, SA 5005

Cancer Australia



2010 PdCCRS: Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma - a randomised phase III trial. App1009485

$650,111.00 01/03/2011 60 Sydney, NSW 2006

Cancer Australia



2010 PdCCRS: A randomised, placebo-controlled trial of concurrent cediranib [AZD2171] with platinum - based chemotherapy & maintenance cediranib in women with platinum sensitive relapsed ovarian cancer: ICON 6. App1006602

$270,597.80 01/03/2011 24 Sydney, NSW 2006

Cancer Australia



2010 PdCCRS: Tumour protein D52 over-expression and DNA repair in cancer. App1007020

$48,132.40 01/03/2011 12 Sydney, NSW 2006

Cancer Australia



2010 PdCCRS: START Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed with Favourable Risk Prostate Cancer. App1004932

$329,320.20 01/03/2011 38 Sydney, NSW 2006

Cancer Australia



2010 PdCCRS: Meeting the education and support needs of women with breast cancer who are referred for radiotherapy: A multiple - baseline study. App1006458

$220,993.30 01/03/2011 59 Perth, WA 6845

Cancer Australia



2010 PdCCRS: A novel approach to predict metastatic potential of prostate cancer at diagnosis. App1012337

$650,905.20 01/03/2011 36 Adelaide, SA 5005

Cancer Priority-driven University of 2010 PdCCRS: The impact of $48,129.40 01/03/2011 12 Sydney, NSW 200615 of 54


Program Component

(if applicable)


Grant Term

(months)



Sydney

aberrant progesterone signalling on lineage specification during early malignant transformation. App1009094

Cancer Australia



2010 PdCCRS: Alternative lengthening of Telomeres (ALT) in lung cancer: analysis of effects on patient outcomes and development of a blood test. App1012032

$48,981.90 01/03/2011 12 Sydney, NSW 2006

Cancer Australia



2010 PdCCRS: NITRO - A randomised, phase 3 trial of adding nitro-glycerine to first line chemotherapy for advanced non - small cell lung cancer. App1006315

$656,421.70 01/03/2011 36 Sydney, NSW 2006

Cancer Australia



Cancer Institute NSW

Maintaining the eviQ Primary Health Care modules $119,900.00 01/03/2011 16

Australian Technology Park,

NSW2015

Cancer Australia



The Australian Lung Foundation

Travel grants for lung cancer nurses to attend the International Lung Cancer Conference in Amsterdam

$22,800.00 29/03/2011 6 Bowen Hills, QLD 4006

Cancer Australia



Queensland Health

Cancer care coordination for Indigenous people residing in Far North Queensland

$438,743.80 25/05/2011 18 Brisbane, QLD 4000

Cancer Australia


Monash University

2010 PdCCRS: Determining the causes of observed variation in survival after diagnosis of prostate cancer. App1010384

$627,607.20 30/05/2011 36 Clayton, VIC 3800

Cancer Australia



Clinical Oncology Society of Australia

Building Cancer Support Networks Initiative - Better Cancer Support through Consumers (BCSN)

$2,970,000.00 02/06/2011 12 Sydney. NSW 2010

Cancer Australia Data Improved

Cancer ControlWomen's and Children's Hospital

For the provision of Pilot Testing of a Data Set Specifications (DSS) for Adolescents and Young Adults with Cancer

$16,648.50 24/06/2011 5 North Adelaide, SA 5006

Cancer Australia



Sequencing the ovarian cancer genome: molecular determinants of tumour growth & treatment failure. App1004673

$660,000.00 30/06/2011 36 Parkville, VIC 3010

Cancer Australia


Queensland University of Technology

Skin cancer prevention & early detection for Generation Y. App1011999

$343,776.40 30/06/2011 36 Brisbane, QLD 4001

16 of 54


Program Component

(if applicable)


Grant Term

(months)



Cancer Control Austin Health

Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period.

$35,255.54 30/06/2011 6 Heidelberg VIC 3084


Cancer ControlPrince Charles Hospital


$18,820.20 30/06/2011 6 Chermside, QLD 4032


Cancer Control

Royal Hobart Hospital (Department of Health and Human Services)


$12,425.24 30/06/2011 6 Hobart, TAS 7000


Cancer Control Nepean Hospital


$27,056.13 30/06/2011 6 Penrith, NSW 2751


Cancer ControlPeter MacCallum Cancer Centre

For the provision of Pilot Testing of a Data Set Specifications (DSS) for Adolescents and Young Adults with Cancer

$36,960.00 30/06/2011 5 A'Beckett Street, VIC 8006


Cancer ControlSouth Eastern Sydney Local Health District


$16,376.80 27/07/2011 4 Randwick, NSW 2031

Cancer Australia



Breast Cancer Network Australia

For the provision of projects that aim to strengthen support for women with breast cancer

$1,366,200.00 04/11/2011 31 Camberwell, VIC 3124

Cancer Australia



2011 PdCCRS – The role of adjuvant chemotherapy in high-risk endometrial cancer. App1027151

$330,965.80 09/01/2012 47 Sydney, NSW 2006

Cancer Australia



2011 PdCCRS – Phase III trial of Concurrent and Adjuvant Temozolomide chemotherapy in non-1p/19q non deleted anaplastic glioma - The CATNON Intergroup Trial.

$217,896.25 09/01/2012 36 Sydney, NSW 2006

17 of 54


Program Component

(if applicable)


Grant Term

(months)


App1026842

Cancer Australia



2011 PdCCRS - Evaluation of a web-based tool for estimating and explaining prognosis in advanced cancer. App1032121

$139,933.75 09/01/2012 48 Sydney, NSW 2006

Cancer Australia



2011 PdCCRS - Evaluation of a psychological and educational intervention for fear of cancer recurrence; A cluster randomised controlled trial. App1022584

$182,124.07 09/01/2012 64 Sydney, NSW 2006

Cancer Australia



Breast Cancer Network Australia Hope and Hurdles Pack $165,000.00 01/02/2012 5 Camberwell, VIC 3124

Cancer Australia


Ludwig Institute for Cancer Research

2011 PdCCRS - Discovery of colorectal cancer subtype associated tumour suppressor genes using next-generation sequencing and high throughput functional genomics. App1030098

$482,476.50 02/02/2012 36 Heidelberg, VIC 3084

Cancer Australia


Edith Cowan University

2011 PdCCRS - Can exercise ameliorate treatment toxicity during the initial phase of testosterone suppression in prostate patients? Is this more effective than delayed rehabilitation and what is the time course and persistence of benefits? App1029901

$163,634.45 02/02/2012 46 Joondalup, WA 6027

Cancer Australia



2011 - PdCCRS 'ReCaPTure LiFe': A phase 11 randomised trial of a psychological intervention to support adolescent and young adult cancer survivors. App1022868

$148,811.45 17/02/2012 36 Sydney, NSW 2052

Cancer Australia



2011 - PdCCRS - The role of p53-regulated microRNAs in epithelial to mesenchymal transition, and their potential as therapeutic targets against metastatic breast cancer. App1034561

$24,750.00 17/02/2012 12 Sydney. NSW 2010

Cancer Australia


Menzies Research Institute

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Integrative genomic approaches to

$567,270 17/02/2012 68 Hobart, TAS 7000

18 of 54


Program Component

(if applicable)


Grant Term

(months)


Schemeunderstanding the genetics of prostate cancer. App ID: 544938; Ref: CA-A0809/11

Cancer Australia


University of Wollongong

2011 - PdCCRS -Quantifying the impact of imaging choice for breast cancer radiotherapy. App1033237

$143,585.20 21/02/2012 41 Wollongong, NSW 2522

Cancer Australia


The State of Queensland through Queensland Health via The Princess Alexandra Hospital Metro South District

2011 - PdCCRS - A randomised Phase III trial of High Dose Palliative Radiotherapy (HDPRT) versus concurrent Chemotherapy and HDPRT (C-HDPRT) in patients with Good performance Status. Locally Advanced/Small Volume Metastatic Non-small Cell Lung Cancer not suitable for Radical Chemo-therapy. App1030265

$327,214.80 21/02/2012 72 Woolloongabba, QLD 4102

Cancer Australia


University of Western Australia

2011 - PdCCRS - The initiation of the cellular immune response to cutaneous melanoma. App1034730

$24,750.00 21/02/2012 12 Heidelberg, VIC 3084

Cancer Australia



2011 - PdCCRS - Inhibition of Glioblastoma Invasion by Novel Dynamin Ring Stabilisers. App1021331

$24,399.38 21/02/2012 12 Sydney, NSW 2006

Cancer Australia



2011 - PdCCRS - Mechanism of 133p53 isoform oncogenicity. App1030408

$24,399.38 21/02/2012 12 Sydney, NSW 2006

Cancer Australia



2011 - PdCCRS - Ginkgo biloba preserves cognitive function in women treated with adjuvant chemotherapy for early breast cancer: a double-blind, placebo-controlled, randomised phase III trial. App1029819

$220,000.00 21/02/2012 71 Sydney, NSW 2006

Cancer Australia



2011 - PdCCRS - The role of Single Stranded DNA Binding Proteins in the Alternative Lengthening of Telomeres mechanism. App1030040

$48,798.75 21/02/2012 24 Sydney, NSW 2006

Cancer Australia

Priority-driven Collaborative


2011 - PdCCRS - The use of RNAi to identify new $411,650.80 21/02/2012 36 Sydney, NSW 2006

19 of 54


Program Component

(if applicable)


Grant Term

(months)



therapeutic targets for malignant mesothelioma. App1031821

Cancer Australia



2011 PdCCRS - Targeting dormancy in metastatic breast cancer. App1020272

$148,179.90 23/02/2012 36 Melbourne, VIC 3010

Cancer Australia



2011 PdCCRS - Defining the hereditary contribution to ovarian cancer: The role of mismatch repair genes. App1024096

$614,090.40 23/02/2012 41 Melbourne, VIC 3010

Cancer Australia



Breast Cancer Network Australia My Journey Kit $248,600.00 23/02/2012 6 Camberwell, VIC 3124

Cancer Australia



2011 - PdCCRS - Thromboembolism in Cancer. App1026790

$24,750.00 20/03/2012 20 Sydney, NSW 2052

Cancer Australia



2011 - PdCCRS - Determining Predictors of Sensitivity to Chk Inhibitors in Metastatic Melanoma. App1029585

$651,585.00 20/03/2012 46 Melbourne , VIC 3010

Cancer Australia



2011 - PdCCRS - Salinomycin a potential glioma stem cell targeting therapy. App1031303

$240,862.50 20/03/2012 12 Brisbane, QLD 4006

Cancer Australia



2011 - PdCCRS - Androgen receptor action in the prostate cancer microenvironment. App1032970

$316,571.20 20/03/2012 43 Adelaide, SA 5005

Cancer Australia



2011 - PdCCRS - Reactivating the p53 pathway as a novel therapeutic approach to cancer treatment. App1034715

$49,500.00 20/03/2012 24 Adelaide, SA 5005

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2011 - A novel method to detect and characterise dysplasia and early cancer in Barrett's oesophagus. Appl ID: 1031971

$24,750 20/03/2012 24 Adelaide, SA 5005

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme $290,766.30 20/03/2012 48 Adelaide, SA 5005

20 of 54


Program Component

(if applicable)


Grant Term

(months)



(PDCCRS) 2011: Is elevated N-cadherin expression a poor prognostic indicator in multiple myeloma patients. Appl ID: 1030518

Cancer Australia



2011 - PdCCRS - The therapeutic potential of targeting S100A2 calcium-binding protein in pancreatic cancer. App1033781

$44,362.50 03/04/2012 27 Callaghan, NSW 2308

Cancer Australia

Supporting People with Cancer Grant initiative


Cancer Council South Australia

Supporting people with Cancer grant initiative $85,800.00 12/06/2012 24 Eastwood, SA 5063

Cancer Australia



The Prince Charles Hospital

Supporting people with Cancer grant initiative $88,000.00 12/06/2012 30 Brisbane, QLD 4032

Cancer Australia



Paediatric Integrated Cancer Service

Supporting people with Cancer grant initiative. CA-A1112/42

$86,361.00 12/06/2012 25 Parkville, VIC 3056

Cancer Australia



Australian Lung Foundation

Supporting people with Cancer grant initiative $83,050.00 12/06/2012 24 Bowen Hills, QLD 4006

Cancer Australia


Improved Cancer Control BreaCan Supporting people with

Cancer grant initiative $88,000.00 12/06/2012 24 Melbourne, VIC 3000

Cancer Australia



Cancer Council VIC

Supporting people with Cancer grant initiative $86,460.00 12/06/2012 24 Carlton, VIC 3053

Cancer Australia


Improved Cancer Control CanRevive Supporting people with

Cancer grant initiative $87,934.00 25/06/2012 24 Sydney, NSW 2000

Cancer Australia



The Medical Oncology Group of Australia

To support the attendance at the ACORD Workshop of four (4) early career oncology clinical researchers from Australia selected as participants and the attendance as a faculty member of the Cancer Australia Chair in Quality of Life Research.

$24,750.00 26/06/2012 1 Sydney, NSW 2000

Cancer Australia

Supporting People with Cancer Grant


Cancer Voices Victoria

Supporting people with Cancer grant initiative

$84,392.00 27/06/2012 24 Carlton, VIC 3053

21 of 54


Program Component

(if applicable)


Grant Term

(months)


initiative

Cancer Australia



Australian Cancer Survivorship

Supporting people with Cancer grant initiative $88,000.00 28/06/2012 25 East Melbourne, VIC 3002

Cancer Australia



Cancer Council NSW

Supporting people with Cancer grant initiative $88,000.00 28/06/2012 25 Woolloomooloo, NSW 2011

Cancer Australia




Supporting people with Cancer grant initiative $82,500.00 28/06/2012 24 Adelaide, SA 5000

Cancer Australia



Menzies School of Health and Research

Supporting people with Cancer grant initiative $87,774.00 29/06/2012 24 Spring Hill, QLD 4000

Cancer Australia



Cancer Council TAS

Supporting people with Cancer grant initiative $16,702.40 29/06/2012 24 Hobart, TAS 7000

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative


Wellington Aboriginal Corporation

For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities

$2,260 03/10/2012 3 Wellington, NSW 2820

Cancer Australia



Top End Remote Health Branch


$2,500 03/10/2012 3 Winnellie, NT 822

Cancer Australia



South Coast Medical Service Aboriginal Corporation


$2,490 03/10/2012 3 Nowra, NSW 2541

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant


Napranum Primary Health Care Clinic

For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in

$1,850 03/10/2012 3 Wiepa, QLD 4874

22 of 54


Program Component

(if applicable)


Grant Term

(months)


Initiative Aboriginal and Torres Strait Islander communities

Cancer Australia



Kalwun Development Corporation Limited


$2,500 03/10/2012 3 Miami, QLD 4220

Cancer Australia



Inala Community Health Centre


$1,600 03/10/2012 3 Inala, QLD 4077

Cancer Australia



Illawarra Womens Health Centre


$2,500 03/10/2012 3 Warilla, NSW 2528

Cancer Australia



Goulburn Valley Health


$2,600 03/10/2012 3 Wodonga, VIC 3689

Cancer Australia



Western NSW Local Health District, Dubbo Community Health Centre


$4,000 03/10/2012 3 Dubbo, NSW 2830

Cancer Australia



Dareton Primary Health Centre


$1,500 03/10/2012 3 Dareton, NSW 2717

Cancer Aboriginal and Improved Bulgarr Ngaru For funding recipients to $4,000 03/10/2012 3 Grafton, NSW 125623 of 54


Program Component

(if applicable)


Grant Term

(months)


Australia

Torres Strait Islander Well Women’s Workshop Grant Initiative

Cancer Control Medical Aboriginal Corporation

implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities

Cancer Australia

Aboriginal and Torres Strait Islander Registered Training Organisation Grants

Indigenous Wellbeing Centre Ltd

To conduct unit of competency and provide information and support to women with breast cancer for Aboriginal and/or Torres Strait Islander Health Workers.

$11,000 26/10/2012 7.5 Bundaberg QLD 4670

Cancer Australia


QLD Aboriginal and Torres Strait Islander Health Worker Education Program Aboriginal Corporation


$11,000 26/10/2012 7.5 Cairns, QLD 4870

Cancer Australia


Central Australian Remote Health Development Services Ltd

To conduct unit of competency and provide information and support to women with breast cancer for Aboriginal and/or Torres Strait Islander Health Workers

$11,000 28/11/2012 7 Alice Springs 870

Cancer Australia


Kimberley Aboriginal Medical Services Council Inc


$11,000 28/11/2012 6 Broome 6725

Cancer Australia


Cancer Council Queensland

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Improving the Psychosocial Health of People with Cancer and their Carers: A Community-Based Approach. App561701. CA-A0809/07

$297,156.20 13/01/2013 47 Fortitude Valley 4006

Cancer Australia

Ralph Lauren Pink Pony 12-13

Ralph Lauren Pink Pony Campaign Scholarships $17,500 14/02/2013 10 Various Various

Cancer Australia


Southern Adelaide Local Area Health Network: Repatriation General Hospital

Prostate Cancer Data Set Specification Pilot Project $19,121.81 25/02/2013 5 Daws Park 5041

24 of 54


Program Component

(if applicable)


Grant Term

(months)


Cancer Australia



Murrumbidgee Medicare Local


$2,800 28/02/2013 5 Tumut, NSW 2720

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: High Risk genes for Lobular Breast Cancer. Appl ID 1047347.

$100,000 01/03/2013 36 Parkville 3010

Cancer Australia


University of Technology Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Molecular characterisation of a novel target in multiple myeloma. Appl ID 1050067.

$23,745.25 01/03/2013 15 Broadway 2007

Cancer Australia


The Australian National University

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Equivalence of sun exposure and vitamin D supplementation in vitamin D insufficiency. Appl ID 1045198

$582,911 01/03/2013 58 Acton 200

Cancer Australia


Walter and Eliza Hall Institute of Medical Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Innate immune cell protection and colon cancer. Appl ID 1050241

$26,826.53 01/03/2013 12 Parkville 3052

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: PETACC-6: Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer. Appl ID 1048035

$123,331 04/03/2013 49 The University of Sydney 2006

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Production of Off The Shelf T-cells Expressing a Non-MHC Restricted CD19 Specific Chimeric Antigen Receptor for use in a Phase I Study of

$47,500 04/03/2013 37 University of Sydney 2006

25 of 54


Program Component

(if applicable)


Grant Term

(months)


T-cell Therapy of Relapsed and Refractory Bcell Malignancies (UNI-T Study). Appl ID 1047454

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Investigating the mechanism of action of the cancer-associated enzyme telomerase using disease linked telomerase mutants. Appl ID 1048376

$24,972.75 04/03/2013 12 University of Sydney 2006

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: The cost-effectiveness of adjuvant whole brain radiotherapy for melanoma brain metastases: a trial-based and modelled economic evaluation. Appl ID 1046923


Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: ICON8: An international multi-stage randomised phase III trial of dose-fractionated chemotherapy compared to standard three-weekly chemotherapy for women with newly diagnosed epithelial ovarian cancer. Appl ID 1044344


Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: The Use and Impact of High Cost Targeted Cancer Medicines: Theory and Reality. Appl ID 1050648


Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Testing of biomarkers of human papillomavirus on anal cytology in homosexual men to predict the presence of high-grade anal intraepithelial neoplasia and its progression and

$48,137.50 11/03/2013 32 Kensington 2232

26 of 54


Program Component

(if applicable)


Grant Term

(months)


persistence. Appl ID 1043299

Cancer Australia



2009 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Translation of clinical and functional imaging data to brachytherapy treatment optimisation for prostate cancer ApplID: 628592

$86,395.83 27/03/2013 48 Parkville VIC 3010

Cancer Australia



2008 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Improving Outcomes for Women with Endometrial Cancer: Follow-up, survival and quality of life ApplID: 552468

$656,466.80 27/03/2013 60 Herston QLD 4006

Cancer Australia


Monash University

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Defining Epigenetic Changes in Prostate Cancer Stroma. Appl ID 1044458

$597,987 31/03/2013 36 Clayton 3800

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Characterising a new mode of regulation of the beta-catenin pathway in colorectal cancer. Appl ID 1049846.

$49,945.50 01/04/2013 24 Darlinghurst 2010

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Mechanism and targeting of castration-resistant prostate cancer. Appl ID 1043482.

$270,569 01/04/2013 36 Adelaide 5005

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Targeting the androgen receptor in triple negative breast cancer. Appl ID 1043497.

$196,474.70 01/04/2013 36 Adelaide 5005

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Investigating the tumour-promoting phenotype of cancer-associated fibroblasts in serous


27 of 54


Program Component

(if applicable)


Grant Term

(months)


epithelial ovarian cancer. Appl ID 1050101

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Mirena ± Weight Loss to treat early Endometrial Cancer: (MAxWEL Trial). Appl ID 1044900

$600,000 01/04/2013 36 Kelvin Grove 4059

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Preferences for adjuvant chemotherapy in early non-small-cell lung cancer: what makes it worthwhile?: ApplID: 570905


Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Genomic determinants of chemosensitivity in ovarian cancer ApplID: 632595


Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Novel MicroRNA regulators in the Breast Cancer EMT ApplID: 628720

$281,620.90 18/04/2013 46 Parkville VIC 3010

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: A pharmacodynamic study of the heat shock protein 90 (Hsp90) inhibitor, AUY922, in high-risk, localised prostate cancer. Appl ID 1050880.

$360,977 01/05/2013 59 Adelaide 5005

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Randomised phase III study of preop-chemoradiotherapy versus preop-chemotherapy for resectable gastric cancer: Appl ID: 570996


Cancer Australia


Anti-Cancer Council of Victoria

Capturing information on clinical stage, metastases at diagnosis and cancer recurrence employing IT solutions

$1,647,499 07/05/2013 42 Carlton, VIC 3053

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme $459,525 23/05/2013 59 University of Sydney 2006

28 of 54


Program Component

(if applicable)


Grant Term

(months)



(PDCCRS) 2008: The use and impact of cancer medicines in real world clinical practice: Evaluation in a cohort of elderly Australians. Appl ID: 568773

Cancer Australia


Peter MacCallum Cancer Centre

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Randomised phase III trial to assess response adapted therapy using PET in newly diagnosed advanced Hodgkin Lymphoma. Appl ID: 628842

$124,666.67 23/05/2013 42 Peter MacCallum Cancer Centre 3002

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: RNA Loading of Tumour Associated Antigens and the Activation of Blood Dendritic Cells for Prostate Cancer Immunotherapy: Appl ID: 543713


Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Solving Unknown Primary cancER – SUPER. Appl ID 1048193.

$599,381 01/06/2013 61 Parkville 3010

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Accelerating First-Line Chemotherapy to Improve Cure Rates for Advanced Germ Cell Tumours: An Australian-Led, International Randomised Trial. Appl ID 1041733


Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Adding mitomycin C to intravesical BCG for high-risk, non-muscle-invasive bladder cancer: a randomised phase 3 trial. Appl ID 1041651


Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Germline Copy Number Variants are

$24,420.50 01/06/2013 19 Herston 4028

29 of 54


Program Component

(if applicable)


Grant Term

(months)


SchemeGenetic Risk Factors for Familial Colorectal Cancer. Appl ID 1052035

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: RAD51 overexpression regulates pro-metastatic gene expression profiles of aggressive metastatic triple negative breast cancer. Appl ID 1050903

$24,764 01/06/2013 12 Herston 4028

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: A Phase II study to evaluate the safety and potential benefit of intraperitoneal (IP) bevacizumab to control symptomatic malignant ascites in patients with chemotherapy resistant ovarian cancers: REZOLVE (ANZGOG-1101). Appl ID 1050134

$277,958 28/06/2013 36 The University of Sydney, NSW 2006

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: Identification of novel permissive mutations representing acquired vulnerabilities in lung cancer - CA-A1314/20 ApplID: 1070515

$50,000 04/02/2014 47 Herston, QLD 4028

Cancer Australia



2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Regulating BAK and BAX conversion to death-inducing oligomers. App1069567 - CA-A1314/18

$27,500 15/02/2014 12 Parkville, VIC 3052

Cancer Australia



2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): From functional genomics to precision medicine: The therapeutic potential of targeting Rho/ROCK signalling in pancreatic cancer. App1065022 - CA-A1314/04

$599,997 17/02/2014 36 Darlinghurst, NSW 2010

30 of 54


Program Component

(if applicable)


Grant Term

(months)


Cancer Australia


Princess Alexandra Hospital

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): A Randomised Trial of Postoperative Radiation Therapy Following Wide Excision of Neurotropic Melanoma of the Head and Neck. App1060687 Ref: CA1314-12

$335,000 20/02/2014 48 Woolloongabba, Qld 4102

Cancer Australia



2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Understanding DNA integrity and telomerase in acute myeloid leukaemia stem cell function. App 1059292: CA-A1314/17

$25,000 27/02/2014 12 Herston, QLD 4028

Cancer Australia


Ludwig Institute for Cancer Research

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Targeting the dimerisation arm of EGFR- biological effects and therapeutic implications. App 1063413: CA-A1314/23

$28,167.98 27/02/2014 24 Heidelberg, VIC 3084

Cancer Australia


University of NSW

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: A multicentre phase II randomised controlled trial of a parent/carer-targeted intervention to improve quality of life in families of young cancer survivors. ID 1065428. CA-A1314/02

$457,353 27/02/2014 48 Kensington 2052

Cancer Australia



2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Maximising benefits and minimising harms in the BreastScreen program: a population health economics modelling approach. App 1066771: CA-A1314/06

$593,893 05/03/2014 48 Parkville, VIC 3010

Cancer Australia



2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Mimicking the HSC niche and enabling HSC self-renewal in vitro.

$50,000 05/03/2014 24 Kelvin Grove, QLD 4059

31 of 54


Program Component

(if applicable)


Grant Term

(months)


App1060928: CA-A1314/21

Cancer Australia



2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): miRSNPs as novel diagnostic and prognostic biomarkers for prostate cancer. App 1068321: CA-A1314/22

$50,000 05/03/2014 24 Kelvin Grove, QLD 4059

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: ECHO trial: Exercise during CHemotherapy for Ovarian cancer. ID 1063509

$300,000 18/03/2014 36 Sydney 2006

Cancer Australia



2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in men at higher genetic risk and controls – The IMPACT study. App 1059423: CA-A1314/01

$292,151 21/03/2014 44 Parkville, VIC 3010

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: Quantifying genetic risk in sarcoma and translation into health outcomes. ID1067094. CA-A1314/09

$597,793 21/03/2014 36 University of Melbourne 3010

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: Novel Therapies to Treat Brain Metastatic Breast Cancer. ID 1067045. CA-A1314/10

$398,447 28/03/2014 36 University of Melbourne 3010

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: ASCOLT: Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers. An International, Multi-centre, Double Blind, Randomised Trial. ID1068044. CA-A1314/08

$276,811.50 28/03/2014 36 Sydney 2006

Cancer Australia


Monash University 2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Nuclear receptors and their functions in breast cancer

$49,518.50 01/04/2014 24 Clayton, VIC 3800

32 of 54


Program Component

(if applicable)


Grant Term

(months)


stroma: identification of novel therapeutic targets. App 1058516: CA-A1314/19

Cancer Australia



2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Investigation of molecular imaging and serum biomarkers to identify lung injury and enable individualised radiation therapy for lung cancers. App1060919

$498,012 01/04/2014 49 Parkville, VIC 3010

Cancer Australia


Monash University

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): An inhalable dendrimer-based delivery platform for the targeted treatment of primary and secondary lung cancers. App 1070184: CA-A1314/11

$452,383 23/04/2014 36 Clayton, VIC 3800

Cancer Australia


Paediatric Integrated Cancer Service

Supporting people with Cancer grant initiative $86,361.00 16/05/2014 25 Parkville VIC 3052

Cancer Australia


The Prince Charles Hospital

Supporting people with Cancer grant initiative $88,000.00 16/05/2014 30 Brisbane, QLD 4032

Cancer Australia



2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Phase 2 study of aromatase inhibitors in women with potentially hormone sensitive recurrent/metastatic gynaecological neoplasms: PARAGON. App 1063014: CA-A1314/69

$546,676 20/05/2014 36 The University of Sydney, NSW 2006

Cancer Australia

Jeannie Ferris Cancer Australia Recognition Award 2014

Various

To recognise outstanding contribution in gynaecological cancer through the Jeannie Ferris Cancer Australia Recognition Award

$4,000 26/05/2014 NA

Cancer Australia



2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): A randomised trial of

$320,000 01/06/2014 43 Parkville, VIC 3010

33 of 54


Program Component

(if applicable)


Grant Term

(months)


Scheme

stereotactic radiotherapy versus conventional radiotherapy for stage I non-small cell lung cancer. App1060822 Ref: CA-1314/14

Cancer Australia


Arts out West Inc

To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/04

$2,200 05/06/2014 3 Bathurst, NSW 2795

Cancer Australia


Cancer Council NT Inc


$4,400 05/06/2014 3 Casuarina, NT 810

Cancer Australia


Central and North West Queensland Medicare Local


$3,993 05/06/2014 3 Normanton QLD 4890

Cancer Australia


Country Health SA Local Health Network Inc


$3,000 05/06/2014 3

Cancer Australia


Hume Regional Integrated Cancer Service


$3,410 05/06/2014 3 Shepparton, VIC 3630

Cancer Australia


Institute for Urban Indigenous Health


$1,650 05/06/2014 3

Cancer Australia

Aboriginal and Torres Strait Islander Well

Jacaranda Community Centre

To use Cancer Australia’s Community Education Resources to hold a Well

$1,870 05/06/2014 3 Cloverdale QLD 6985

34 of 54


Program Component

(if applicable)


Grant Term

(months)


Women’s Workshop Grant Initiative

Women Workshop. Ref: CA-G1415/13

Cancer Australia


Kurranulla Aboriginal Corporation


$2,200 05/06/2014 3 Jannali NSW 2226

Cancer Australia


Malabam Health Board Aboriginal Corporation


$3,696 05/06/2014 3 Maingride NT 822

Cancer Australia


Metro South Addictions & Mental Health Service


$2,750 05/06/2014 3 Upper Mount Gravatt QLD 4122

Cancer Australia


MiiMi Aboriginal Corporation


$2,750 05/06/2014 3 Bowraville NSW 2449

Cancer Australia


Pika Wiya Health Service


$3,000 05/06/2014 3 Port Augusta SA 5700

Cancer Australia


Walgett AMS


$4,400 05/06/2014 3 Walgett NSW 2832

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop

Went West Limited


$2,200 05/06/2014 3 Blacktown NSW 2148

35 of 54


Program Component

(if applicable)


Grant Term

(months)


Grant Initiative

Cancer Australia


Menzies School of Health Research


$4,000 06/06/2014 3 Brisbane QLD 4000

Cancer Australia


Liverpool Women’s Health Centre


$1,430 06/06/2014 3 Liverpool NSW 1871

Cancer Australia


Oak Valley Maralinga Incorporated


$2,750 06/06/2014 3 Ceduna SA 5690

Cancer Australia


Winanga-Li


$2,860 06/06/2014 3 Gunnedah NSW 2380

Cancer Australia


University of NSW

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: MRP4 and MRP3 transporters: potential new targets in ovarian cancer. ID1067110. CA-A1314/71

$589,989 10/06/2014 36 Sydney 2052

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: REZOLVE: A Phase II study to evaluate the safety and potential palliative benefit of intraperitoneal bevacizumab in patients with symptomatic ascites due to advanced chemotherapy resistant gynaecological cancers. ID1067589. CA-A1314/70

$119,280 10/06/2014 36 Sydney 2006

Cancer Australia

Supporting People with

Cancer Council South Australia

Supporting people with Cancer grant initiative $85,800.00 10/06/2014 31 Eastwood, SA 5063

36 of 54


Program Component

(if applicable)


Grant Term

(months)


Cancer Grant initiative

Cancer Australia


La Trobe University

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): A Randomised phase II trial of Adaptive Image guided standard or Dose Escalated Radiotherapy in the treatment of transitional cell carcinoma of the Bladder (RAIDER-B). App1063072 Ref: CA1314-03

$280,000 16/06/2014 54 Melbourne, VIC 3086

Cancer Australia



2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Hitting the Target: Real-Time Prostate Cancer Radiotherapy. App1064731 Ref: CA1314-05

$171,854 16/06/2014 36 Sydney, NSW 2006

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: High risk genes for childhood cancer: using massively parallel sequencing to identify cancer susceptibility ID1070106

$200,000.00 17/06/2014 30 Parkville 3010

Cancer Australia


Inala Indigenous Health


$2,255 17/06/2014 3 Inala, QLD 4077

Cancer Australia


Maari Ma Health Aboriginal Corporation


$2,750 25/06/2014 3 Broken Hill, NSW 2880

Cancer Australia Data

The Flinders University of South Australia

To collect data in order to assess the Testicular Cancer Data Set Specification

$16,510 26/06/2014 8 Bedford Park, SA 5042

Cancer Australia Data

Adventist HealthCare Limited


$22,000 27/06/2014 8 Wahroonga, NSW 2076

Cancer Australia

Data Peter MacCallum Cancer Institute T/A Peter


$20,000 27/06/2014 8 Melbourne, VIC 8006

37 of 54


Program Component

(if applicable)


Grant Term

(months)


MacCallum Cancer Centre

Cancer Australia

Improving evidence base

Lung Cancer Foundation Australia

Review and update the “Lung Cancer – understanding, managing, living” DVD Ref: CA-G1415/24

$16,500.00 30/06/2014 4 Milton, QLD 4064

Cancer Australia



2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Identification of the critical p53 tumor suppression mechanisms in vivo. App 1067571 - CA-A1314/15

$27,361.68 14/07/2014 12 Parkville, VIC 3052

Cancer Australia

Ralph Lauren Pink Pony seeding grant

Cancer Council Tasmania

Ralph Lauren Pink Pony seeding grants: Cancer Council Tasmania will deliver free Pilates classes to women in rural and remote areas. The classes are specifically designed for women with breast cancer to increase core and general strength, decrease fatigue, improve sleep and overall wellbeing and provide opportunity for social interaction. The classes are currently run from a metropolitan centre and will be extended to women in rural and remote areas via video conferencing facilities. Ref: CA-G1415/31

$9,460 16/07/2014 12 Hobart, TAS 7000

Cancer Australia


Support4Cancer The Support4Cancer project recognises that male partners caring for women with breast cancer have their own unmet supportive care needs which can have a detrimental impact on their wellbeing and also affect their ability to provide support for their wives during the breast cancer journey. The project will deliver two region-wide community forums seeking to address some of these unmet supportive care needs, which will be of

$$4,900 24/07/2014 12 Ballarat, VIC 3350

38 of 54


Program Component

(if applicable)


Grant Term

(months)


benefit to male partners and women affected by breast cancer.

Cancer Australia

Supporting Women in Rural Areas Diagnosed with Breast Cancer


My Journey Kit, Hope and Hurdles and promotion of Stay in Touch Ref: CA-G1415/35

$2,619,100 01/08/2014 36 Camberwell, VIC 3122

Cancer Australia


Dandenong Ranges Music Council Incorporated

Ralp Lauren Pink Pony seeding grant - outreach program for women living with breast cancer. Ref: CA-G1415/36

$8,861.50 15/08/2014 12 Upwey, VIC 3158

Cancer Australia


Tharawral Aboriginal Corporation


$1,100 31/08/2014 3 Campbelltown, NSW 2560

Cancer Australia



2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS):Pain Free TRUS B: A placebo-controlled, randomised trial of methoxyflurane to reduce the discomfort of prostate biopsy. App.1079794: CA-G1415/40


Cancer Australia



2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Reducing Thoracic Imaging Dose and Improving Image Quality in Radiotherapy Treatments. App.1084566: CA-G1415/41


Cancer Australia



2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS):Real-time Six Degree of Freedom Tumour Motion Management in Cancer Radiotherapy. App.1085360: CA-G1415/42


Cancer Australia



2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Molecular Functions of the


39 of 54


Program Component

(if applicable)


Grant Term

(months)


Scheme

Iron Regulated Metastasis Suppressor, NDRG1 and its Potential as a Molecular Target. App.1086449: CA-G1415/43

Cancer Australia


The Council of the Queensland Institute of Medical Research

2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Targeting suppressive TGF-βR and A2AR pathways in natural killer (NK) cells: Enhancing the anti-metastatic response against breast cancer progression. App.1082709: CA-G1415/44

$50,000.00 27/11/2014 12 Herston 4028

Cancer Australia


The Council of the Queensland Institute of Medical Research

2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Eph Receptor Tyrosine Kinases as Targets for Therapy in Paediatric Medulloblastoma. App.1080218: CA-G1415/45

$66,573.00 27/11/2014 24 Herston 4028

Cancer Australia



2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Targeting neuropilin-1 to inhibit prostate cancer metastasis and therapy resistance. App.1088878: CA-G1415/46

$63,870.00 27/11/2014 24 Kelvin Grove 4059

Cancer Australia



2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Phase III trial of Concurrent & Adjuvant Temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma. App.1078665: CA-G1415/39


Cancer Australia



2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): SCOT - Short Course Oncology Therapy - A study of adjuvant chemotherapy in colorectal cancer. App. 1086013: CA-G1415/49


Cancer Australia



2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): ANZMTG 01.07 Whole Brain


40 of 54


Program Component

(if applicable)


Grant Term

(months)


Scheme

Radiotherapy (WBRT) following local treatment of intracranial metastases of melanoma – a randomised phase III trial. App. 1084046: CA-G1415/50

Cancer Australia



2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): ANZMTG 01.12 RADICAL – RADiotherapy (RT) or Imiquimod (ImiQ) in Complex lentigo mALigna (LM). App. 1083221: CA-G1415/51


Cancer Australia



2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Identification of HNF1B downstream targets as novel cancer therapeutic targets and biomarkers. App. 1086830: CA-G1415/52

$100,000 13/04/2015 30 Kelvin Grove 4059

Cancer Australia



2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Molecular hallmarks of heat shock protein 90 inhibition in prostate cancer. App. 1085471: CA-G1415/53

$553,483 24/04/2015 36 Adelaide 5005

Cancer Australia


Australian National University

2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Novel combination therapies targeting the ribosome to treat prostate cancer (PC). App. 1084546: CA-G1415/54

$599,492 28/04/2015 36 Acton 200

Cancer Australia



2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS):SPARK: Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring. App. 1081534: CA-G1415/55


Cancer Australia



2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Evaluating combination therapies in FGFR2mutant

$600,000 01/05/2015 36 Kelvin Grove 4059

41 of 54


Program Component

(if applicable)


Grant Term

(months)


EC cell lines and patient-derived xenograft models.. App. 1087165: CA-G1415/56

Cancer Australia


The University of Western Australia

2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Mammographic density as a predictor of breast cancer risk and mortality in Western Australian Aboriginal women. App. 1085750: CA-G1415/59

$137,651 04/05/2015 32 Crawley 6009

Cancer Australia



2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Investigating the safety and efficacy, quality of life, cost-efficiency and immune potential of high precision lung radiotherapy. App. 1082399: CA-G1415/63

$439,418 03/06/2015 36 Parkville 3010

Cancer Australia


Lung Foundation Australia

Supporting people with Cancer grant initiative: Nurse-led lung cancer support service Ref: CA-G1516/02

$132,000 04/06/2015 36 Milton 4064

Cancer Australia


Rare Cancers Australia Ltd

Supporting people with Cancer grant initiative: Rare Cancers Patient Support Program. Ref: CA-G1516/01

$132,000 04/06/2015 36 Bowral 2576

Cancer Australia


Cancer Council NSW

Supporting people with Cancer grant initiative: Develop and implement online, audio-visual webinar information sessions in Mandarin and Cantonese to address the unmet needs of people in the Chinese community who are affected by cancer; and compile existing supportive care services and resources available to the Chinese community. Ref: CA-G1516/07

$122,100 09/06/2015 36 Woolloomooloo 2011

Cancer Australia



Supporting people with Cancer grant initiative: Engage the Vietnamese community to develop culturally-specific resources and a supporting community

$120,000 12/06/2015 36 Parkville 3010

42 of 54


Program Component

(if applicable)


Grant Term

(months)


engagement campaign to raise awareness about cancer symptoms and promote earlier presentation to healthcare in the Vietnamese community. Ref: CA-G1516/08

Cancer Australia



2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): The feMMe trial. App. 1078121: CA-G1415/60

$540,000 16/06/2015 36 St Lucia 4072

Cancer Australia

2015-2016 Ralph Lauren Pink Pony Seeding Grant

Cancer Council Northern Territory

2015-2016 Ralph Lauren Pink Pony seeding grant: Yoga for Life - To support community based initiatives that aim to improve access to information, support and services for women with breast cancer in communities in Australia. Ref: CA-G1415/65

$11,000 24/06/2015 12 Wanguri 810

Cancer Australia


Ishar Multicultural Women's Health Centre

2015-2016 Ralph Lauren Pink Pony seeding grant: Pink Ladies - To establish a support program for women form culturally and linguistically diverse backgrounds with breast cancer. Ref: CA-G1415/64

$11,000 25/06/2015 12 Mirrabooka 6061

Cancer Australia


Boronia Multicultural Services

2015-2016 Ralph Lauren Pink Pony seeding grant: Swasthi (Wellbeing) - To train community volunteers to support South-Asian women with breast cancer. Ref: CA-G1415/66

$11,000 26/06/2015 12 Toongabbie 2146

Cancer Australia


Anti-Cancer Council TA Cancer Council Victoria

Ralph Lauren Pink Pony seeding grants: Anti-Cancer Council Victoria will deliver an online interactive resource that links women seeking face-to-face support to Cancer Council Victoria support groups in their local area. The support groups offer people with cancer a chance to meet regularly and talk about common issues and connect with others who've been through

$8,861.50 30/06/2015 12 Melbourne, VIC 3004

43 of 54


Program Component

(if applicable)


Grant Term

(months)


a similar cancer journey. The online resource will enable women to identify groups that best meet their personal needs by enabling them to search for support groups for women with a particular stage of cancer, identify the distance they are able to travel, and whether the group welcomes carers of family members. Ref: CA-G1415/32

Cancer Australia


University of Western Australia

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2015: Identification of the molecular networks that drive mesothelioma invasion: ID1107743. Ref: CA-G1516/10

$38,676 27/01/2016 12 Crawley 6009

Cancer Australia

Supporting People with Cancer Grant initiative round 8

Lung Foundation Australia

This project will develop and deliver a set of patient-centred evidence based webinars to improve health literacy and assist patients to more effective self-manage their condition and connect them with the services they need.

$132,000 28/01/2016 36 Milton 4064

Cancer Australia

Supporting People with Cancer Grant initiative round 8

Menzies School of Health Research

This project will develop a knowledge transfer and implementation framework for supportive care needs for Indigenous Australian along the cancer continuum.

$131,472 29/01/2016 36 Tiwi 801

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2015: Targeting the IL-3/IL-3 receptor axis to prevent breast cancer progression: ID1105828. Ref: CA-G1516/11

$290,983 02/02/2016 36 Adelaide 5001

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2015: The role of long-non coding RNAs in Acute Myeloid Leukaemia: ID1100978. Ref: CA-G1516/13

$49,605 04/02/2016 12 Ultimo 2007

Cancer Supporting Brain Tumour Provide a core set of $85,000 05/02/2016 36 Pearce 260744 of 54


Program Component

(if applicable)


Grant Term

(months)


AustraliaPeople with Cancer Grant initiative round 8

Alliance Australia

information suitable for brain tumour patients, their carers and family members to improve health and quality of life outcomes for people affected by brain tumours.

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2015: From mice to men: biomarker-driven classification of pancreatic cancer to define the gemcitabine/ nab-paclitaxel-responsive molecular subtype: ID1100722. Ref: CA-G1516/12

$600,000 15/02/2016 36 Darlinghurst 2010

Cancer Australia



Developing a Patient-Reported Symptom Index for Non-muscle Invasive Bladder Cancer: ID1103036 Ref: CA-G1516/19


Cancer Australia



Developing a rapid and quantitative telomere length test to measure chemotherapeutic response to telomerase inhibition: ID1099299 Ref: CA-G1516/20


Cancer Australia



Improving the cure rates of childhood brain cancer ID1101390 Ref: CA-G1516/22


Cancer Australia



Generation and use of novel model systems to study steroid hormone action in the breast: ID1098796 Ref: CA-G1516/23


Cancer Australia



Phase II randomised placebo-controlled, double blind, multisite study of acetazolamide versus placebo for management of cerebral oedema in recurrent and/or progressive HGG requiring treatment with dexamethasone – The ACED trial: ID1098932 Ref: CA-G1516/24


Cancer Priority Driven University of Adjuvant chemotherapy with $497,544 29/02/2016 36 The University of 200645 of 54


Program Component

(if applicable)


Grant Term

(months)



Sydney

gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 Trial): ID1100306 Ref: CA-G1516/25

Sydney

Cancer Australia



Long-term follow-up of the Laparoscopic Approach to Carcinoma of the Endometrium (LACE) Trial – survival outcomes: ID1098905 Ref: CA-G1516/28

$380,674 07/03/2016 24 St Lucia 4072

Cancer Australia


Melbourne Health

CaPP3: a randomized double blind dose inferiority trial of aspirin in Lynch Syndrome: ID1103035 Ref: CA-G1516/29

$290,340.50 11/03/2016 36 Parkville 3056

Cancer Australia



A novel approach to overcome treatment-resistance in breast cancer: ID1107170 Ref: CA-G1516/30

$415,770 11/03/2016 36 Darlinghurst 2010

Cancer Australia



Translating Evidence into Practice: Optimising and Facilitating Prevention and Screening in Women with a Strong Family History of Breast Cancer: ID1100868 Ref: CA-G1516/31

$258,345 15/03/2016 36 Parkville 3010

Cancer Australia


Peter MacCallum Cancer Institute T/A Peter MacCallum Cancer Centre

Improving information provision and support for underserved cancer survivors. Ref: CA-G1516/36

$132,000 30/03/2016 25 Melbourne 3000

Cancer Australia



Confidence to Care: A multi-state randomised controlled trial of structured nurse-led home-based support and education for carers of people with high grade glioma.: ID1105307 Ref: CA-G1516/33

$535,789 06/04/2016 36 Perth 6102

Cancer Australia



ICON9: A phase 3 randomised trial of cediranib and olaparib maintenance in patients with relapsed platinum sensitive ovarian

$600,000 06/04/2016 36 The University of Sydney

2006

46 of 54


Program Component

(if applicable)


Grant Term

(months)


cancer: ID1100619 Ref: CA-G1516/34

Cancer Australia



The PEARL trial: Palliative care Early in Advanced Lung cancers: ID1101882 Ref: CA-G1516/37


Cancer Australia



Resolution of the missing heritability of breast cancer: ID1107870 Ref: CA-G1516/38

$299,822 03/05/2016 36 Parkville 3010

Cancer Australia


La Trobe University

A multistage multi centre international randomised trial of Conventional care Or Radioablation(stereotactic body radiotherapy) for Extra-cranial oligometastatic disease in lung, breast and prostate cancer (CORE): ID1104569 Ref: CA-G1516/32

$430,563 16/05/2016 36 Bundoora 3086

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2015: Counting the Cost of Curing Childhood ALL by Transplantation. ID1102140. CA-G1516/39

$350,000 30/05/2016 36 Sydney 2006

Cancer Australia


Bloomhill Cancer Care

Support community-based initiatives that aim to improve access to information, support and services for women with breast cancer in Australia: Bloomfield Lymphodema Information, Support and Services (BLISS) project. Ref: CA-G1516/42

$6,200.28 15/06/2016 12 Buderim 4556

Cancer Australia


CanRevive Inc.

Support community-based initiatives that aim to improve access to information, support and services for women with breast cancer in Australia: Information for Chinese women affected by Breast Cancer project. Ref: CA-G1516/43

$11,000.00 15/06/2016 12 Sydney 2000

Cancer Australia

Aboriginal and Torres Strait Islander Well

Cancer Council New South Wales

Support community-based initiatives that aim to improve access to

$11,000.00 15/06/2016 12 Woolloomooloo 2011

47 of 54


Program Component

(if applicable)


Grant Term

(months)


Women’s Workshop Grant Initiative

information, support and services for women with breast cancer in Australia: Yarning about cancer - Supporting indigenous Breast Cancer Peer Support Group leaders project. Ref: CA-G1516/44

Cancer Australia


Westmead Breast Cancer Institute

Supporting Indigenous women with breast cancer - Delivering breast cancer education workshops to Aboriginal and Torres Strait Islander health workers project. Ref: CA-G1516/41

$10,000.00 17/06/2016 12 North Sydney 2060

Cancer Australia


University of Technology, Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Randomised double blind placebo controlled phase III trial of oral melatonin for the prevention of delirium in hospital in people with advanced cancer: ID1127727. Ref: CA-G1516/54

$599,820.00 03/03/2017 36 Ultimo 2007

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Development of a Clinico-Molecular Colon Cancer Nomogram for personalisation of adjuvant chemotherapy in the Australian population: ID1120882. Ref: CA-G1516/56

$594,254.00 08/03/2017 36 Parkville 3052

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Computed tomography (CT) and positron emission tomography (PET)/CT surveillance imaging in asymptomatic Stage III melanoma patients - a prospective cohort study of clinical benefit and economic implications: ID1129568. Ref: CA-G1516/57

$481,698.00 08/03/2017 36 The University of Sydney 2006

48 of 54


Program Component

(if applicable)


Grant Term

(months)


Cancer Australia


Lowy Cancer Research Centre, University of NSW

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia - a novel epigenetic mechanism linked to lymphocyte-specific chromatin conformation: ID1129129. Ref: CA-G1516/52

$296,428.50 10/03/2017 36 Kensington 2052

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: ASCOLT: Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers. An International, Multi-centre, Double Blind, Randomised Trial: ID1122632 Ref: CA-G1516/51


Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Targeting FACT to inhibit MYCN-driven transcription in neuroblastoma: ID1123235 Ref: CA-G1516/53

$496,055.50 17/03/2017 36 Kensington 2052

Cancer Australia


Council of the Queensland Institute of Medical Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Improving Natural Killer cell responses to immunotherapy in haematological cancers: ID1122183. Ref: CA-G1516/59

$49,669.50 17/03/2017 12 Herston 4006

Cancer Australia


Sydney Children's Hospital, University of NSW

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Synthetic retinoid therapy for Diffuse Intrinsic Pontine Gliomas: ID1126580. Ref: CA-G1516/66

$200,000.00 23/03/2017 36 Kensington 2052

Cancer Australia


University of Melbourne Centre for Cancer Research

Supporting people with cancer Grant initiative 2017, Round 9: PanSupport- an experience based co-design, supportive care app with and for people affected by pancreatic cancer. Ref: CA-G1617/81

$115,000.00 27/03/2017 36 Parkville 3052

49 of 54


Program Component

(if applicable)


Grant Term

(months)


Cancer Australia


Cancer Council Australia

Supporting people with cancer Grant initiative 2017, Round 9: Production of psychosocial and information resources for Australians with less common cancers. Ref: CA-G1617/82

$128,405.00 27/03/2017 36 Sydney 2000

Cancer Australia


North Metropolitan Health Service

Supporting people with cancer Grant initiative 2017: Adolescent and Young Adult (AYA) Life Now Group Exercise Program. Ref: CA-G1617/80

$112,462.00 30/03/2017 36 Nedlands 6009

Cancer Australia


Walter & Eliza Hall Institute of Medical Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Transcriptional control of IL-17 producing T cells in gastrointestinal cancers: ID1123388. Ref: CA-G1516/76

$98,222.00 31/03/2017 24 Parkville 3052

Cancer Australia


Prince of Wales Hospital, University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Phase III Intergroup Study of Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy with Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma: the CODEL trial: ID1130584. Ref: CA-G1516/67


Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Reprogramming the Tumour Microenvironment with the use of Nanomedicines for the Treatment of Pancreatic Cancer: ID1126736. Ref: CA-G1516/69

$247,983.25 04/04/2017 36 Sydney 2052

Cancer Australia


Council of the Queensland Institute of Medical Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Dnmt3a loss contributes to disease progression in myeloproliferative

$100,000.00 04/04/2017 24 Herston 4006

50 of 54


Program Component

(if applicable)


Grant Term

(months)


neoplasm: ID1124096. Ref: CA-G1516/77

Cancer Australia


Macquarie University

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Differential effects of MAPK inhibition on immune activity determine melanoma response: ID1123911. Ref: CA-G1516/78

$2,078.50 04/04/2017 24 Macquarie University 2109

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Phase II clinical trial of the PARP inhibitor, olaparib, in HR- deficient advanced breast and ovarian cancer in women without inherited BRCA1 or BRCA2 mutations: ID1128740. Ref: CA-G1516/71


Cancer Australia


Australian National University

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: AUTO-CHECK study: Molecular determinants of autoimmunity and immune related adverse events in advanced cancer patients treated with immune checkpoint inhibitors: ID1130330. Ref: CA-G1516/74

$574,009.00 10/04/2017 36 Acton 2601

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: High Precision Radiotherapy: Dual Cardiac and Respiratory Motion Management: ID1123068. Ref: CA-G1516/55


Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: The SPAR Trial: a randomised placebo-controlled phase 2 trial of simvastatin with preoperative chemoradiation for rectal cancer. ID1125958. Ref: CA-G1617/85


51 of 54


Program Component

(if applicable)


Grant Term

(months)


Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Assessing Behaviour Change Techniques for Indigenous Pregnant Smokers attending Aboriginal Medical Services - a nested study in a cluster Randomised Controlled Trial. ID 1125695. CA-G1516/75.

$50,000 08/06/2017 12 Callaghan 2308

Cancer Australia


University of NSW

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Therapeutically targeting a solute carrier transporter in the stroma of pancreatic cancer. ID1126738. Ref: CA-G1617/84

$511,966.00 13/06/2017 36 Kensington 2052

Cancer Australia


Cancer Council New South Wales

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Hide and seek with hereditary cancer: Improving detection of colorectal cancer patients with a high risk of Lynch syndrome. ID1123924 CA-G1516/70.

$579,140 13/06/2017 36 Woolloomooloo 2011

Cancer Australia


Australia New Zealand Gynaecological Oncology Group

Supporting People with Cancer Grant Initiative, 2017, Round 9: Survivors Teaching Students: Saving Women's lives. Ref: CA-G1617/87

$132,000.00 15/06/2017 36 Camperdown 2050

Cancer Australia


University of NSW

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Improving outcomes for high risk ALL treated with new therapies and transplant. ID1128727. Ref: CA-G1617/86

$600,000.00 16/06/2017 36 Kensington 2052

Cancer Australia



Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: A phase III wait-listed RCT of a novel targeted inter-professional clinical education intervention to improve cancer patients’ reported pain outcomes. ID1127011 Ref: CA-G1617/83

$342,483.00 19/06/2017 36 Ultimo 2007

Cancer Priority Driven University of Priority Driven Collaborative $242,789 21/06/2017 24 Crawley 600952 of 54


Program Component

(if applicable)


Grant Term

(months)



Western Australia

Cancer Research Scheme (PDCCRS) 2016: FGF-Receptor Antagonist in Mesothelioma (FRAME) Study: A Phase II Clinical Trial. ID1121215. CA-G1516/68

Cancer Australia


Cancer Council Victoria

Supporting People with Cancer Grant Initiative, 2017, Round 9: Keeping Things on Track. Ref: CA-G1617/88

$131,230.00 21/06/2017 36 Melbourne 3004

Cancer Australia



Supporting people with Cancer grant initiative: Develop and disseminate evidence-based, culturally appropriate and in-language resources for Greek and Chinese women affected by secondary breast cancer. Ref: CA-G1516/03

$131,552.30 30/06/2105 36 Camberwell 3124

Cancer Australia


Cancer Council Australia

Supporting people with Cancer grant initiative: Develop a culturally-specific and accessible web-based resource to meet the identified needs of specific CALD communities affected by cancer. Ref: CA-G1516/04

$132,000 30/06/2105 36 Sydney 2000

Cancer Australia


Cancer Council QLD

Supporting people with Cancer grant initiative: Design and deliver evidence-based cancer control courses for Aboriginal and Torres Strait Islander health workers and build local cancer support networks for Aboriginal and Torres Strait Islander people affected by cancer living in regional and rural Queensland. Ref: CA-G1516/05

$132,000 30/06/2105 36 Fortitude Valley 4006

Cancer Australia


Aboriginal Health and Medical Research Council NSW

Supporting people with Cancer grant initiative: : Develop locally led Aboriginal cancer networks to support local communities affected by cancer. Ref: CA-G1516/06

$132,000 30/06/2105 36 Surry Hills 2010

53 of 54

54 of 54

cancer australia - grants reporting · web view2017/07/03 · priority driven collaborative cancer...

Documents